Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NUVB
NUVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NUVB News
Nuvation Bio (NUVB) Shares Hit Oversold Territory with RSI at 29.5
Jan 12 2026
NASDAQ.COM
Seeking Alpha Releases Q4 Stock Ratings, Micron and Others Rated Strong Buy
Jan 12 2026
seekingalpha
Nuvation Bio (NUVB) Reports $15.7M Q4 Revenue and $25M Milestone Payment from Nippon Kayaku
Jan 12 2026
seekingalpha
Nuvation Bio and Eisai Sign Exclusive Collaboration, Securing $60 Million Upfront Payment
Jan 12 2026
Businesswire
Nuvation Bio and Eisai Form Strategic Collaboration to Expand Taletrectinib's Global Reach
Jan 12 2026
Newsfilter
Nuvation Bio (NUVB): Reevaluating Valuation Following a 78% Increase in Share Price Over the Past Month
Dec 17 2025
Yahoo Finance
Nuvation Bio (NUVB) Receives Upgrade to Buy: Key Information You Need to Know
Dec 15 2025
NASDAQ.COM
Innovent's Seven Innovative Drugs Included in 2025 NRDL
Dec 07 2025
PRnewswire
Innovent Biologics Secures Inclusion of Seven Innovative Drugs in 2025 NRDL
Dec 07 2025
Newsfilter
Innovent Reveals Addition of Seven Innovative Medications, Including New Indication for TYVYT and SYCUME, to China's National Reimbursement Drug List
Dec 07 2025
Yahoo Finance
Nuvation Bio Executive Offloaded Shares Valued at $1,173,255, Recent SEC Filing Reveals
Dec 03 2025
Yahoo Finance
Nuvation Bio Stock Jumps 8.4% Following Encouraging Phase 2 Results for Grade-2 IDH1 Glioma
Dec 03 2025
NASDAQ.COM
Nuvation Bio Reports 44% ORR for Safusidenib in Phase 2 Study
Dec 03 2025
Newsfilter
HC Wainwright & Co. Affirms Buy Rating for Nuvation Bio, Keeps $10 Price Target Intact
Dec 01 2025
Benzinga
Nuvation Bio Halts Development of NUV-1511
Nov 26 2025
SeekingAlpha
Nuvation Bio Gains Momentum as B. Riley Initiates Buy Rating on Promising Lead Drug Launch
Nov 19 2025
SeekingAlpha
Show More News
